Bolzano
In Bolzano province 84,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 7 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-e...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2008-09-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1002 |
| _version_ | 1818676201459286016 |
|---|---|
| author | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_facet | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_sort | Maria Caterina Cavallo |
| collection | DOAJ |
| description | In Bolzano province 84,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 7 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-effective (40.541 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 6 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Bolzano province, the net cost for woman vaccinated is 216 € for the single cohort and 218 € for the multiple cohort. |
| first_indexed | 2024-12-17T08:39:43Z |
| format | Article |
| id | doaj.art-321be669b2db4a02a1302d580912f862 |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-12-17T08:39:43Z |
| publishDate | 2008-09-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-321be669b2db4a02a1302d580912f8622022-12-21T21:56:23ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2008-09-0191S232510.7175/fe.v9i1S.1002938BolzanoMaria Caterina Cavallo0Filippo Cipriani1Simone Gerzeli2Nadia Demarteau3Alessia Marocco4Francesco Bamfi5Università Bocconi, MilanoGlaxoSmithKline Spa, VeronaDipartimento di Statistica ed Economia Applicate L. Lenti, Università di PaviaGlaxoSmithKline Biologicals, Wavre (Belgio)GlaxoSmithKline Spa, VeronaGlaxoSmithKline Spa, VeronaIn Bolzano province 84,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 7 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-effective (40.541 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 6 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Bolzano province, the net cost for woman vaccinated is 216 € for the single cohort and 218 € for the multiple cohort.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1002bolzanohpv vaccinationeconomic & clinical impact |
| spellingShingle | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi Bolzano Farmeconomia: Health Economics and Therapeutic Pathways bolzano hpv vaccination economic & clinical impact |
| title | Bolzano |
| title_full | Bolzano |
| title_fullStr | Bolzano |
| title_full_unstemmed | Bolzano |
| title_short | Bolzano |
| title_sort | bolzano |
| topic | bolzano hpv vaccination economic & clinical impact |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1002 |
| work_keys_str_mv | AT mariacaterinacavallo bolzano AT filippocipriani bolzano AT simonegerzeli bolzano AT nadiademarteau bolzano AT alessiamarocco bolzano AT francescobamfi bolzano |